European Society of Toxicology In Vitro > News > ESTIV President, Dr. Helena Kandarova is the recipient of the 2022 EUROTOX Award Lecture
22 September 2022

ESTIV President, Dr. Helena Kandarova is the recipient of the 2022 EUROTOX Award Lecture

ESTIV President, Dr. Helena Kandarova is the recipient of the 2022 EUROTOX Lecture! Many congratulations.

About the award:

The EUROTOX Lecture (replacing the former Bo Holmstedt Lecture) was established in 2022 and recognises scientists who have made outstanding scientific contributions to the science of drug and chemical toxicology, or related areas. 

Nominations should be active, mid-career scientists involved in toxicology research in the public or private sector that are making substantial and innovative scientific contributions in the field of toxicological sciences.  

Particular emphasis is given to recent research contributions, and advanced knowledge of European toxicology with an internationally appeal. Scientific accomplishment is the prime consideration in the evaluation review process.

The first recipient of the 2022 EUROTOX Lecture is Dr. Helena Kandarova (Slovakia).

Related content

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

Silver Sponsor

Communication partners

Memorandum of Understanding